KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to -$482.0 million.

  • Medtronic's Cash from Investing Activities fell 3971.01% to -$482.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$2.5 billion, marking a year-over-year decrease of 2625.81%. This contributed to the annual value of -$1.9 billion for FY2025, which is 1813.19% up from last year.
  • As of Q4 2025, Medtronic's Cash from Investing Activities stood at -$482.0 million, which was down 3971.01% from -$719.0 million recorded in Q3 2025.
  • In the past 5 years, Medtronic's Cash from Investing Activities ranged from a high of $1.9 billion in Q2 2021 and a low of -$2.8 billion during Q1 2021
  • For the 5-year period, Medtronic's Cash from Investing Activities averaged around -$575.5 million, with its median value being -$514.5 million (2023).
  • Examining YoY changes over the last 5 years, Medtronic's Cash from Investing Activities showed a top increase of 42575.34% in 2021 and a maximum decrease of 990000.0% in 2021.
  • Medtronic's Cash from Investing Activities (Quarter) stood at -$709.0 million in 2021, then plummeted by 61.64% to -$1.1 billion in 2022, then skyrocketed by 63.0% to -$424.0 million in 2023, then grew by 18.63% to -$345.0 million in 2024, then tumbled by 39.71% to -$482.0 million in 2025.
  • Its Cash from Investing Activities stands at -$482.0 million for Q4 2025, versus -$719.0 million for Q3 2025 and -$490.0 million for Q2 2025.